PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
0.34 - 0.34
0.23 - 0.41
110.0K / 51.2K (Avg.)
-1.33 | -0.26
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-42.78%
Both firms have declining sales. Martin Whitman would suspect an industry slump or new disruptive entrants.
77.20%
Gross profit growth under 50% of 8198.HK's 705.68%. Michael Burry would be concerned about a severe competitive disadvantage.
No Data
No Data available this quarter, please select a different quarter.
-33.94%
Negative operating income growth while 8198.HK is at 448.29%. Joel Greenblatt would press for urgent turnaround measures.
-25.15%
Both companies face declining net income. Martin Whitman would suspect external pressures or flawed business models in the space.
-18.18%
Both companies exhibit negative EPS growth. Martin Whitman would consider sector-wide issues or an unsustainable business environment.
-18.18%
Both face negative diluted EPS growth. Martin Whitman would suspect an industry or cyclical slump with heightened share issuance across the board.
-0.00%
Share reduction while 8198.HK is at 0.00%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
123.88%
OCF growth of 123.88% while 8198.HK is zero. Bruce Berkowitz would see if small gains can expand into a larger competitive lead.
123.76%
FCF growth of 123.76% while 8198.HK is zero. Bruce Berkowitz would see if modest improvements in free cash can accelerate further.
-93.25%
Both companies have negative long-term revenue/share growth. Martin Whitman would question if the entire market or product set is shrinking.
-93.14%
Both face negative 5Y revenue/share CAGR. Martin Whitman would suspect macro headwinds or obsolete product offerings across the niche.
-58.39%
Both firms have negative 3Y CAGR. Martin Whitman would wonder if the entire market segment is in short-term retreat.
120.58%
10Y OCF/share CAGR at 50-75% of 8198.HK's 228.04%. Martin Whitman might fear a structural deficiency in operational efficiency.
-91.36%
Negative 5Y OCF/share CAGR while 8198.HK is at 136.49%. Joel Greenblatt would question the firm’s operational model or cost structure.
-73.60%
Both face negative short-term OCF/share growth. Martin Whitman would suspect macro or cyclical issues hitting them both.
-299.67%
Both face negative decade-long net income/share CAGR. Martin Whitman would suspect a shrinking or highly disrupted sector.
-4.68%
Both exhibit negative net income/share growth over five years. Martin Whitman would suspect a challenging environment for the entire niche.
-585.45%
Negative 3Y CAGR while 8198.HK is 7.57%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
-20.51%
Negative equity/share CAGR over 10 years while 8198.HK stands at 119.09%. Joel Greenblatt sees a fundamental red flag unless the competitor also struggles.
-24.42%
Both show negative equity/share growth mid-term. Martin Whitman suspects cyclical or structural challenges for each company.
-26.46%
Both show negative short-term equity/share CAGR. Martin Whitman suspects an industry slump or unprofitable expansions for both players.
-100.00%
Cut dividends over 10 years while 8198.HK stands at 0.00%. Joel Greenblatt suspects a weaker ability to return capital vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
7.78%
AR growth of 7.78% while 8198.HK is zero. Bruce Berkowitz wonders if the firm’s additional AR is warranted by strong revenue or potential risk.
-90.78%
Inventory is declining while 8198.HK stands at 0.00%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
-9.38%
Negative asset growth while 8198.HK invests at 0.00%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
-9.37%
We have a declining book value while 8198.HK shows 0.00%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
129.55%
Debt growth of 129.55% while 8198.HK is zero. Bruce Berkowitz sees additional leverage that must yield profitable expansions to be worthwhile.
No Data
No Data available this quarter, please select a different quarter.
18.40%
We expand SG&A while 8198.HK cuts. John Neff might see the competitor as more cost-optimized unless we expect big payoffs from the overhead growth.